Abstract
Tuberculosis is a major cause of death from infection worldwide, in 2011 were recorded 8.7 million cases. The available treatment for this condition has high rates of abandonment, and high levels of resistance of Mycobacterium tuberculosis, its agent, to the drugs used in the therapy. In this sense, is very important to develop more selective drugs, capable of reduce the duration of treat…